The global diabetes burden calls for a holistic approach to advance patient empowerment and access to innovation <br><br> Roche | <br> Monday

Chairs: Partha Kar (UK) Rolf Hinzmann (GER) 16:00 – 16:05 Introduction Partha Kar (UK)Rolf Hinzmann (GER) 16:05 – 16:30 Evolving technologies and therapies: For the many or for the few? Partha Kar (UK) 16:30 – 16:55 Heart failure: a major but underappreciated complication – new ADA guidance Rodica Pop-Busui (USA) 16:55 – 17:20 Enhancing care […]

Where and how does semaglutide fit in the treatment of type 2 diabetes?- A case-based discussion <br><br> Novo Nordisk A/S | <br>Thursday

Chair: Filip Knop (DNK) 11:45 – 11:50 Welcome and IntroductionOverview of semaglutide, PIONEER and SUSTAIN trials Filip Knop (DNK) 11:50 – 12:00 Case based discussions on clinical evidence Filip Knop (DNK)Melanie Davies (UK) 12:00 – 12:05 Patient-centric practicalities Filip Knop (DNK)Melanie Davies (UK) 12:05 – 12:15 Panel discussion, Q&A and closing remarks Filip Knop (DNK)Melanie […]